Infectious Diseases Clinical Trials Network (IDCTN)
Federal opportunity from Public Agency. Place of performance: United States.
Market snapshot
Baseline awarded-market signal across all contracting (sample of 400 recent awards; refreshed periodically).
Related hubs & trends
Navigate the lattice: hubs for browsing, trends for pricing signals.
Applicable Wage Determinations
SAM WDOL references matched to this opportunity's location and scope language.
Point of Contact
Agency & Office
Description
The National Institute of Allergy and Infectious Diseases (NIAID) is seeking to establish a cooperative network to rapidly implement clinical trials for therapeutics, vaccines, biologics, diagnostics, and devices targeting infectious diseases. The network will consist of Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC). The initiative aims to support the evaluation of innovative concepts for advancing public health while mentoring the next generation of clinical... | Title: Infectious Diseases Clinical Trials Network (IDCTN), Agency: U.S. National Institutes of Health, State: United States of America, Open Date: 11/18/2025, Close Date: 6/10/2026, Last Updated Date: 3/2/2026
Files
Files size/type shown when available.
BidPulsar Analysis
A practical, capture-style breakdown of fit, requirements, risks, and next steps.
FAQ
How do I use the Market Snapshot?
It summarizes awarded-contract behavior for the opportunity’s NAICS and sector, including a recent pricing band (P10–P90), momentum, and composition. Use it as context, not a guarantee.
Is the data live?
The signal updates as new awarded notices enter the system. Always validate the official award and solicitation details on SAM.gov.
What do P10 and P90 mean?
P10 is the 10th percentile award size and P90 is the 90th percentile. Together they describe the typical spread of award values.